Firstly and most importantly I don't believe that PLS suck at PR and Promotion. This conclusion by some is the wrong diagnosis of the current malady.
There's a legal issue going on that by nature requires discretionary judgement to what can be publically released. Then there's the issues of the on going BOA's and finance negotiations that also require privacy. Also let's remember that PLS are calling tenders for the mining contract as well.
All issues are tied together and disclosing details of one can be to the detriment of the others.
Frustrating for shareholders it may be but patience and tolerance are required. Early on I said that the MIN issue would delay finalizing and announcing further developments such as the BOAs. I still believe that this is the case.
I have no doubt that the next steps in development are being sorted but we won't hear much until the MIN issue is sorted.
- Forums
- ASX - By Stock
- PLS
- Why does PLS suck at PR and Promotion
Why does PLS suck at PR and Promotion, page-18
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.07 |
Change
0.090(3.02%) |
Mkt cap ! $9.197B |
Open | High | Low | Value | Volume |
$3.05 | $3.09 | $3.02 | $74.82M | 24.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 750 | $3.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 750 | 3.050 |
2 | 44802 | 3.040 |
7 | 195289 | 3.030 |
12 | 445998 | 3.020 |
5 | 26550 | 3.010 |
Price($) | Vol. | No. |
---|---|---|
3.080 | 227736 | 15 |
3.090 | 254756 | 21 |
3.100 | 787128 | 86 |
3.110 | 72903 | 13 |
3.120 | 185976 | 25 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
PLS (ASX) Chart |